MENU
+Compare
DGNOF
Stock ticker: OTC
AS OF
Oct 17 closing price
Price
$0.26
Change
-$0.01 (-3.70%)
Capitalization
26.11M

DGNOF Diagnos Inc. Forecast, Technical & Fundamental Analysis

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy... Show more

DGNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DGNOF with price predictions
Oct 17, 2025

DGNOF sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for DGNOF moved above the 200-day moving average on October 07, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 25, 2025. You may want to consider a long position or call options on DGNOF as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DGNOF just turned positive on September 30, 2025. Looking at past instances where DGNOF's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

DGNOF moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DGNOF advanced for three days, in of 87 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 80 cases where DGNOF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DGNOF moved out of overbought territory on October 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where DGNOF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGNOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DGNOF broke above its upper Bollinger Band on October 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DGNOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DGNOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (108.696) is normal, around the industry mean (21.732). P/E Ratio (0.000) is within average values for comparable stocks, (83.279). DGNOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.618). DGNOF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (384.615) is also within normal values, averaging (70.594).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
DGNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
7005 Taschereau Boulevard
Phone
+1 450 678-8882
Employees
42800
Web
http://www.diagnos.ca
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EIHDF0.55N/A
N/A
888 Holdings plc.
HKTGF270.00N/A
N/A
Hikari Tsughin Inc.
GYUAF23.26N/A
N/A
Gs Yuasa Corp.
EBBNF23.90-0.10
-0.42%
Enbridge Inc.
CRMZ2.55-0.05
-1.92%
CreditRiskMonitor.com, Inc.

DGNOF and Stocks

Correlation & Price change

A.I.dvisor tells us that DGNOF and KNAMF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DGNOF and KNAMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGNOF
1D Price
Change %
DGNOF100%
-5.34%
KNAMF - DGNOF
27%
Poorly correlated
N/A
NEXOY - DGNOF
23%
Poorly correlated
-1.36%
NEXOF - DGNOF
20%
Poorly correlated
N/A
EBYH - DGNOF
10%
Poorly correlated
N/A
LFMD - DGNOF
6%
Poorly correlated
-5.44%
More

Groups containing DGNOF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGNOF
1D Price
Change %
DGNOF100%
-5.34%
Health Services
category (427 stocks)
9%
Poorly correlated
-1.10%
Services to the Health Industry
category (93 stocks)
9%
Poorly correlated
-2.28%